Willis Towers Watson ( WTW ) shares are trading lower on Thursday. The company disclosed that Liberty Specialty Markets (LSM) is now leveraging Neuron, WTW’s digital trading platform, for live trading of Directors & Officers (D&O) and Cyber risks.

LSM’s capacity was activated on Neuron on March 31, 2025. Initially, this will apply to Cyber and D&O business lines, with plans to expand Neuron’s capabilities in 2025 by adding more classes and partners.

Neuron connects brokers and insurers in real-time, streamlining and speeding up the trading of complex specialty risks while improving efficiency throughout the insurance value chain.

By establishing a digital marketplace where participants retain control over their key assets and the flexibility to trade, Neuron is setting the benchmark for connected ecosystems based on transparency and consistency.

Carol Baker, Head of Digital Strategy at LSM, said, “This latest capability to digitally trade D&O and Cyber risks in real time on Neuron underscores LSM’s wider commitment to expand its digital capabilities, offering brokers a faster, more flexible way to trade risks while enabling tailored portfolio underwriting solutions.”

”This also represents the latest step towards a more connected market overall, making the risk placement process fast and frictionless for follow business, strengthened as additional carriers and brokers join.”

Mark Russell-Vick, Head of Broking FINEX GB at Willis, commented, “The London market is rapidly evolving with an increase of capacity becoming attracted to algorithmic capacity offerings. Neuron is breaking new ground which is extremely exciting as we bring future innovations into today’s world for the benefit of global clients.”

Investors can gain exposure to the stock via Litman Gregory Funds Trust Polen Capital International Growth ETF and Touchstone ETF Trust Touchstone International Equity ETF .

Price Action: WTW shares are down 1.16% at $311.17 at the last check on Thursday.

Read Next:

Kevin O’Leary Says Early Retirees Are Making A Big Mistake—’Staying Stimulated Is How People Live Into Their 90s’